CDC website.cdc.gov/vaccines/hcp/vis/vis-statements/hep-b.html. Updated April 5, 2019. Accessed April 30, 2019. Recombivax HB [prescribing information]. Whitehouse, NJ: Merck Sharp & Dohme Corp; 2018. merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf. Accessed April...
th"eAUnCiotemdpSretahtenssRiveecoImmuenidzaattiioonns Softrtahteegy toAdvisoErlyimCinoamtemitTtereanosnmImissmiounnizaotfionHPerpaacttiitcises B(ACVIPir)uPsartInIIf:eIcmtiomnuniznatiothneof UAdnuiteltsd," StatesMorbiRdietycoamndmMenodrtaatliotynsWoefetkhlyeImmunization of Adults,"RAMedopvriobsriodt...
Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis. 2011;11:153. 9. Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141–50. 10. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes...
The polymerase overlapping the S region and the basic core promoter (BCP/PC) of HBV from 32 hepatitis B...doi:10.1016/j.jcv.2015.06.044Kramvis, A.Bell, T.G.Makondo, E.Yousif, M.Mudawi, H.Glebe, D.Elsevier B.V.Journal of Clinical Virology...
Kramvis, T. Roskams, G. Leroux-Roels Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus J. Virol., 80 (2006), pp. 2797-2807 Google Scholar 34 M. Tsuge, N. Hiraga, H. Takaishi, C. Noguchi, H. Oga, M. Imamura, S. Takahashi, E. Iwao, Y. Fujimoto...
11. Baptista, M., Kramvis, A. & Kew, M. C. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29, 946–953 (1999). 12. Blackberg, J. &...
(FDR) discarded, since they have smaller differences between the top and second-highest PSM scores and higher average mass deviations, FIinGigdH.ic2Va)t.1iE-n6vg9el,noItwGua-HclloVy,n31f-i52d01e,unancneiqdmuIeaGtVcHhHVisn3eg-q2du3ue,neoctneostthwheeerbieansitdirsienonsftiipcfiareeldlv...
S Hadziyannis, MA Gerber, C Vissoulis, H Popper Cytoplasmic hepatitis B antigen in “ground-glass” hepatocytes of carriers Arch Pathol, 96 (1973), pp. 327-330 View in ScopusGoogle Scholar 5 H Popper The ground glass hepatocyte as a diagnostic hint Hum Pathol, 6 (1975), pp. 517-520...
carriers (Bianchi & Gudat, 1979; Hadziyannis, Gerber, Vissoulis, & Popper, 1973; Hadziyannis, Merikas, Panetsos, & Kourepi, 1972; Hoofnagle & Alter, 1984). Then, another HBV protein, the hepatitis B e antigen (HBeAg) discovered in 1972 (Magnius & Espmark, 1972), was added as a...
Title: Hepatitis B antiviral agents United States Patent 9066932 Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound...